Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

Deepak M. W. Balak; Gerald J. D. Hengstman; Enes Hajdarbegovic; Rob J. P. van den Brule; Raymond M. M. Hupperts; Hok Bing Thio

doi:10.1186/1471-2377-13-146

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

Deepak M. W. Balak^*, Gerald J. D. Hengstman, Enes Hajdarbegovic, Rob J. P. van den Brule, Raymond M. M. Hupperts, Hok Bing Thio

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	146
Journal	BMC Neurology
Volume	13
Issue number	1
DOIs	https://doi.org/10.1186/1471-2377-13-146
Publication status	Published - 16 Oct 2013

Keywords

Skin reactions
MS
Quality of life
Glatiramer acetate
Interferon-beta
Injections

Access to Document

10.1186/1471-2377-13-146

Cite this

Balak, D. M. W., Hengstman, G. J. D., Hajdarbegovic, E., van den Brule, R. J. P., Hupperts, R. M. M., & Thio, H. B. (2013). Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study. BMC Neurology, 13(1), [146]. https://doi.org/10.1186/1471-2377-13-146

Balak, Deepak M. W. ; Hengstman, Gerald J. D. ; Hajdarbegovic, Enes ; van den Brule, Rob J. P. ; Hupperts, Raymond M. M. ; Thio, Hok Bing. / Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study. In: BMC Neurology. 2013 ; Vol. 13, No. 1.

@article{790be700ce014c4687a37a43e91cffe1,

title = "Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study",

keywords = "Skin reactions, MS, Quality of life, Glatiramer acetate, Interferon-beta, Injections",

author = "Balak, {Deepak M. W.} and Hengstman, {Gerald J. D.} and Enes Hajdarbegovic and {van den Brule}, {Rob J. P.} and Hupperts, {Raymond M. M.} and Thio, {Hok Bing}",

year = "2013",

month = oct,

day = "16",

doi = "10.1186/1471-2377-13-146",

language = "English",

volume = "13",

journal = "BMC Neurology",

issn = "1471-2377",

publisher = "BioMed Central Ltd",

number = "1",

}

Balak, DMW, Hengstman, GJD, Hajdarbegovic, E, van den Brule, RJP, Hupperts, RMM & Thio, HB 2013, 'Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study', BMC Neurology, vol. 13, no. 1, 146. https://doi.org/10.1186/1471-2377-13-146

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study. / Balak, Deepak M. W.; Hengstman, Gerald J. D.; Hajdarbegovic, Enes; van den Brule, Rob J. P.; Hupperts, Raymond M. M.; Thio, Hok Bing.

In: BMC Neurology, Vol. 13, No. 1, 146, 16.10.2013.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

AU - Balak, Deepak M. W.

AU - Hengstman, Gerald J. D.

AU - Hajdarbegovic, Enes

AU - van den Brule, Rob J. P.

AU - Hupperts, Raymond M. M.

AU - Thio, Hok Bing

PY - 2013/10/16

Y1 - 2013/10/16

KW - Skin reactions

KW - MS

KW - Quality of life

KW - Glatiramer acetate

KW - Interferon-beta

KW - Injections

U2 - 10.1186/1471-2377-13-146

DO - 10.1186/1471-2377-13-146

M3 - Article

C2 - 24131589

VL - 13

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

IS - 1

M1 - 146

ER -